Cocrystal pharma reports qtrly loss per share $0.06

Cocrystal pharma reports third quarter 2019 financial results and provides corporate update.cocrystal pharma inc - qtrly loss per share $0.06.cocrystal pharma inc - as of september 30, 2019, company had about $6 million cash on hand.cocrystal pharma inc - expects to have sufficient cash to fund operations through end of 2020.
COCP Ratings Summary
COCP Quant Ranking